*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. A laboratory had published several brochures aimed at health professionals, announcing the
ALERTS : DISTRIBUTION - ADVERTISING - PHARMACEUTICAL SPECIALTY - COMPARATIVE ADVERTISING - MISLEADING PRACTICE
Advertising: The French Supreme Court assesses the legality of an advertisement that presents a pharmaceutical specialty as a generic version of a brand-name drug (Mopral)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.